Publication | Open Access
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
58
Citations
33
References
2018
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1